A daily low dose of aspirin significantly reduces the number of deaths from a whole range of common cancers, an Oxford University study has found.
The 20% drop in all cancer deaths seen in the study adds new evidence to the debate about whether otherwise healthy people in their 40s and 50s should consider taking a low dose of aspirin each day.
The results, published in the Lancet, showed that aspirin reduced death due to any cancer by around 20% during the trials. But the benefits of aspirin only became apparent after taking the drug for 5 years or more, suggesting aspirin works by slowing or preventing the early stages of the disease so that the effect is only seen much later.
2 comments:
And, just to establish bragging rights, Aspirin was created by an A.G. Bayer team headed by my distant ancestor, Heinrich. He was personally credited with developing a second wonder drug, Heroin. They quite mistakenly believed Heroin to be the first, non-addictive opiate, hence the name. Oopsie!
The articles I've seen up that 20% to 60% specifically for lung cancer and specifically for people with a family history of cancer. Personally. I'm picking up some baby aspirins tomorrow.
However they also mention taking them with a glass of milk as it works best in interaction with calcium and as I'm lactose intolerant and I share my bed with someone I like in a room that gets stuffy in winter as it is with the windows closed, I think I'll be substituting calcium supplements.
Post a Comment